Trial · NCT02409667
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period 1, Baseline to Week 24 | STARTED | Treatment Period 1: All Participants | 1,647 | |
| Treatment Period 1, Baseline to Week 24 | STARTED | Treatment Period 2: Group 1 | 0 | |
| Treatment Period 1, Baseline to Week 24 | STARTED | Treatment Period 2: Group 2 | 0 | |
| Treatment Period 1, Baseline to Week 24 | STARTED | Treatment Period 2: Group 3 | 0 | |
| Treatment Period 1, Baseline to Week 24 | STARTED | Treatment Period 2: Group 4 | 0 | |
| Treatment Period 1, Baseline to Week 24 | COMPLETED | Treatment Period 1: All Participants | 1,526 | |
| Treatment Period 1, Baseline to Week 24 | COMPLETED | Treatment Period 2: Group 1 | 0 | |
| Treatment Period 1, Baseline to Week 24 | COMPLETED | Treatment Period 2: Group 2 | 0 | |
| Treatment Period 1, Baseline to Week 24 | COMPLETED | Treatment Period 2: Group 3 | 0 | |
| Treatment Period 1, Baseline to Week 24 | COMPLETED | Treatment Period 2: Group 4 | 0 | |
| Treatment Period 1, Baseline to Week 24 | NOT COMPLETED | Treatment Period 1: All Participants | 121 | |
| Treatment Period 1, Baseline to Week 24 | NOT COMPLETED | Treatment Period 2: Group 1 | 0 | |
| Treatment Period 1, Baseline to Week 24 | NOT COMPLETED | Treatment Period 2: Group 2 | 0 | |
| Treatment Period 1, Baseline to Week 24 | NOT COMPLETED | Treatment Period 2: Group 3 | 0 | |
| Treatment Period 1, Baseline to Week 24 | NOT COMPLETED | Treatment Period 2: Group 4 | 0 | |
| Treatment Period 2, Week 24 to Week 52) | STARTED | Treatment Period 1: All Participants | 0 | |
| Treatment Period 2, Week 24 to Week 52) | STARTED | Treatment Period 2: Group 1 | 644 | |
| Treatment Period 2, Week 24 to Week 52) | STARTED | Treatment Period 2: Group 2 | 662 | |
| Treatment Period 2, Week 24 to Week 52) | STARTED | Treatment Period 2: Group 3 | 114 | |
| Treatment Period 2, Week 24 to Week 52) | STARTED | Treatment Period 2: Group 4 | 93 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02409667/flow